238 related articles for article (PubMed ID: 26844282)
1. A High Level of Intestinal Alkaline Phosphatase Is Protective Against Type 2 Diabetes Mellitus Irrespective of Obesity.
Malo MS
EBioMedicine; 2015 Dec; 2(12):2016-23. PubMed ID: 26844282
[TBL] [Abstract][Full Text] [Related]
2. Intestinal alkaline phosphatase deficiency increases the risk of diabetes.
Malo J; Alam MJ; Islam S; Mottalib MA; Rocki MMH; Barmon G; Tinni SA; Barman SK; Sarker T; Khan MNI; Kaliannan K; Hasanat MA; Rahman S; Pathan MF; Khan AKA; Malo MS
BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 35082135
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Alkaline Phosphatase Deficiency Is Associated with Ischemic Heart Disease.
Malo J; Alam MJ; Shahnaz M; Kaliannan K; Chandra G; Aziz T; Sarker T; Bala M; Paul R; Saha CK; Karmakar PK; Malo MS
Dis Markers; 2019; 2019():8473565. PubMed ID: 31915470
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the gut enzyme intestinal alkaline phosphatase may explain how aspartame promotes glucose intolerance and obesity in mice.
Gul SS; Hamilton AR; Munoz AR; Phupitakphol T; Liu W; Hyoju SK; Economopoulos KP; Morrison S; Hu D; Zhang W; Gharedaghi MH; Huo H; Hamarneh SR; Hodin RA
Appl Physiol Nutr Metab; 2017 Jan; 42(1):77-83. PubMed ID: 27997218
[TBL] [Abstract][Full Text] [Related]
5. Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes.
Lassenius MI; Fogarty CL; Blaut M; Haimila K; Riittinen L; Paju A; Kirveskari J; Järvelä J; Ahola AJ; Gordin D; Härma MA; Kumar A; Hamarneh SR; Hodin RA; Sorsa T; Tervahartiala T; Hörkkö S; Pussinen PJ; Forsblom C; Jauhiainen M; Taskinen MR; Groop PH; Lehto M;
J Intern Med; 2017 Jun; 281(6):586-600. PubMed ID: 28393441
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in intestinal alkaline phosphatase, inflammation, and nutrition.
Lallès JP
Nutr Rev; 2019 Oct; 77(10):710-724. PubMed ID: 31086953
[TBL] [Abstract][Full Text] [Related]
7. [The role of intestinal alkaline phosphatase in the development of obesity. Modulation of enzyme activity by high fat diet and dietary fiber].
Efimtseva EA; Chelpanova TI
Vopr Pitan; 2024; 93(1):44-60. PubMed ID: 38555609
[TBL] [Abstract][Full Text] [Related]
8. Dairy products and the French paradox: Could alkaline phosphatases play a role?
Lallès JP
Med Hypotheses; 2016 Jul; 92():7-11. PubMed ID: 27241245
[TBL] [Abstract][Full Text] [Related]
9. A role for intestinal alkaline phosphatase in preventing liver fibrosis.
Liu Y; Cavallaro PM; Kim BM; Liu T; Wang H; Kühn F; Adiliaghdam F; Liu E; Vasan R; Samarbafzadeh E; Farber MZ; Li J; Xu M; Mohad V; Choi M; Hodin RA
Theranostics; 2021; 11(1):14-26. PubMed ID: 33391458
[No Abstract] [Full Text] [Related]
10. Multisystemic functions of alkaline phosphatases.
Buchet R; Millán JL; Magne D
Methods Mol Biol; 2013; 1053():27-51. PubMed ID: 23860646
[TBL] [Abstract][Full Text] [Related]
11. Intestinal alkaline phosphatase to treat necrotizing enterocolitis.
Biesterveld BE; Koehler SM; Heinzerling NP; Rentea RM; Fredrich K; Welak SR; Gourlay DM
J Surg Res; 2015 Jun; 196(2):235-40. PubMed ID: 25840489
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
14. Loss of Intestinal Alkaline Phosphatase Leads to Distinct Chronic Changes in Bone Phenotype.
Kuehn F; Adiliaghdam F; Hamarneh SR; Vasan R; Liu E; Liu Y; Ramirez JM; Hoda RS; Munoz AR; Ko FC; Armanini M; Brooks DJ; Bouxsein ML; Demay MB; Hodin RA
J Surg Res; 2018 Dec; 232():325-331. PubMed ID: 30463736
[TBL] [Abstract][Full Text] [Related]
15. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L
Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
[TBL] [Abstract][Full Text] [Related]
16. Impaired glucose homeostasis in non-diabetic Greek hypertensives with diabetes family history. Effect of the obesity status.
Vyssoulis GP; Liakos CI; Karpanou EA; Triantafyllou AI; Michaelides AP; Tzamou VE; Markou MI; Stefanadis CI
J Am Soc Hypertens; 2013; 7(4):294-304. PubMed ID: 23562108
[TBL] [Abstract][Full Text] [Related]
17. The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract.
Bilski J; Mazur-Bialy A; Wojcik D; Zahradnik-Bilska J; Brzozowski B; Magierowski M; Mach T; Magierowska K; Brzozowski T
Mediators Inflamm; 2017; 2017():9074601. PubMed ID: 28316376
[TBL] [Abstract][Full Text] [Related]
18. Lower circulating irisin is associated with type 2 diabetes mellitus.
Liu JJ; Wong MD; Toy WC; Tan CS; Liu S; Ng XW; Tavintharan S; Sum CF; Lim SC
J Diabetes Complications; 2013; 27(4):365-9. PubMed ID: 23619195
[TBL] [Abstract][Full Text] [Related]
19. Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase.
Economopoulos KP; Ward NL; Phillips CD; Teshager A; Patel P; Mohamed MM; Hakimian S; Cox SB; Ahmed R; Moaven O; Kaliannan K; Alam SN; Haller JF; Goldstein AM; Bhan AK; Malo MS; Hodin RA
Diabetes Obes Metab; 2016 May; 18(5):519-27. PubMed ID: 26876427
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
